B. Schüll

1.2k total citations
17 papers, 860 citations indexed

About

B. Schüll is a scholar working on Oncology, Dermatology and Otorhinolaryngology. According to data from OpenAlex, B. Schüll has authored 17 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 4 papers in Dermatology and 3 papers in Otorhinolaryngology. Recurrent topics in B. Schüll's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (8 papers) and Pancreatic and Hepatic Oncology Research (4 papers). B. Schüll is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (8 papers) and Pancreatic and Hepatic Oncology Research (4 papers). B. Schüll collaborates with scholars based in Austria and United States. B. Schüll's co-authors include Gabriela Kornek, Werner Scheithauer, Markus Raderer, D. Depisch, Katharina Schmid, Bruno Schneeweiß, H. Ulrich-Pur, Fritz Lang, W. Millesi and Edgar Selzer and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

B. Schüll

17 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Schüll Austria 14 639 250 172 163 128 17 860
B. Mirtsching United States 12 1.1k 1.8× 459 1.8× 104 0.6× 288 1.8× 131 1.0× 27 1.3k
M Hunt United States 13 590 0.9× 267 1.1× 408 2.4× 157 1.0× 80 0.6× 21 1000
Rodolfo Mattioli Italy 17 707 1.1× 306 1.2× 48 0.3× 128 0.8× 141 1.1× 61 995
Anwar Tarabichi Germany 14 401 0.6× 224 0.9× 95 0.6× 201 1.2× 196 1.5× 19 786
L. Leong United States 16 648 1.0× 241 1.0× 100 0.6× 143 0.9× 238 1.9× 41 1.0k
Frank Peters Netherlands 13 425 0.7× 323 1.3× 40 0.2× 236 1.4× 70 0.5× 32 754
Seizo Masutani Japan 12 367 0.6× 210 0.8× 56 0.3× 139 0.9× 214 1.7× 37 712
A.K. Kakkar United Kingdom 13 273 0.4× 120 0.5× 376 2.2× 150 0.9× 135 1.1× 28 1.0k
H. Ulrich-Pur Austria 17 707 1.1× 370 1.5× 40 0.2× 170 1.0× 263 2.1× 29 951
C. Sternberg Italy 16 397 0.6× 606 2.4× 159 0.9× 228 1.4× 225 1.8× 67 1.1k

Countries citing papers authored by B. Schüll

Since Specialization
Citations

This map shows the geographic impact of B. Schüll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Schüll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Schüll more than expected).

Fields of papers citing papers by B. Schüll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Schüll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Schüll. The network helps show where B. Schüll may publish in the future.

Co-authorship network of co-authors of B. Schüll

This figure shows the co-authorship network connecting the top 25 collaborators of B. Schüll. A scholar is included among the top collaborators of B. Schüll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Schüll. B. Schüll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ulrich-Pur, H., Markus Raderer, Gabriela Kornek, et al.. (2003). Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma. British Journal of Cancer. 88(8). 1180–1184. 98 indexed citations
2.
3.
Schmid, Katharina, Gabriela Kornek, B. Schüll, et al.. (2003). Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed. Oncology Research and Treatment. 26(3). 255–258. 20 indexed citations
4.
Schüll, B., et al.. (2003). Capecitabine as Salvage Therapy for a Breast Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function. Oncology Research and Treatment. 26(6). 578–580. 16 indexed citations
5.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (2003). Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer. Journal of Clinical Oncology. 21(7). 1307–1312. 141 indexed citations
6.
Scheithauer, Werner, B. Schüll, H. Ulrich-Pur, et al.. (2002). Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial. Annals of Oncology. 14(1). 97–104. 149 indexed citations
7.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (2002). Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer. Annals of Oncology. 13(10). 1583–1589. 34 indexed citations
8.
9.
Gedlicka, Claudia, B. Schüll, Michael Formanek, et al.. (2002). Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies. Anti-Cancer Drugs. 13(5). 491–495. 14 indexed citations
10.
Schüll, B., Gabriela Kornek, Katharina Schmid, et al.. (2002). Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen. Oncology Research and Treatment. 25(4). 358–362. 4 indexed citations
11.
Kornek, Gabriela, K. Haider, W. Kwasny, et al.. (2002). Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.. PubMed. 8(5). 1051–6. 40 indexed citations
12.
Kornek, Gabriela, Markus Raderer, B. Schüll, et al.. (2002). Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer. British Journal of Cancer. 86(12). 1858–1863. 32 indexed citations
13.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (2002). Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer. Journal of Clinical Oncology. 20(1). 165–172. 21 indexed citations
14.
Ulrich-Pur, H., Gabriela Kornek, Wolfgang Fiebiger, et al.. (2001). Treatment of Advanced Hepatocellular Carcinoma with Biweekly High-Dose Gemcitabine. Oncology. 60(4). 313–315. 31 indexed citations
15.
Glaser, Christoph, W. Millesi, Gabriela Kornek, et al.. (2001). Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. International Journal of Radiation Oncology*Biology*Physics. 50(3). 705–715. 205 indexed citations
16.
Ulrich-Pur, H., et al.. (2000). Oxaliplatin-Induced Fever and Release of IL-6. Oncology. 59(3). 187–189. 28 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Mirtsching Breakdown of academic impact, for papers by M Hunt Breakdown of academic impact, for papers by Rodolfo Mattioli Breakdown of academic impact, for papers by Anwar Tarabichi Breakdown of academic impact, for papers by L. Leong Breakdown of academic impact, for papers by Frank Peters Breakdown of academic impact, for papers by Seizo Masutani Breakdown of academic impact, for papers by A.K. Kakkar Breakdown of academic impact, for papers by H. Ulrich-Pur Breakdown of academic impact, for papers by C. Sternberg
Rankless by CCL
2026